Seamount Financial Group’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.18M Sell
4,657
-42
-0.9% -$9.79K 0.48% 49
2026
Q1
$1.15M Buy
4,699
+11
+0.2% +$2.56K 0.52% 45
2025
Q4
$970K Sell
4,688
-133
-3% -$26.3K 0.44% 52
2025
Q3
$894K Hold
4,821
0.42% 54
2025
Q2
$736K Buy
4,821
+327
+7% +$50.3K 0.38% 61
2025
Q1
$745K Buy
4,494
+92
+2% +$14.4K 0.51% 51
2024
Q4
$637K Sell
4,402
-312
-7% -$48.3K 0.44% 60
2024
Q3
$764K Buy
4,714
+105
+2% +$16.7K 0.57% 48
2024
Q2
$674K Buy
4,609
+471
+11% +$70K 0.55% 48
2024
Q1
$655K Sell
4,138
-175
-4% -$27.9K 0.57% 50
2023
Q4
$676K Buy
+4,313
New +$661K 0.65% 47

Other funds holding JNJ

Seamount Financial Group's JNJ Position: Q2 2026 in Review

Seamount Financial Group reduced its Johnson & Johnson (JNJ) stake by 0.89% in Q2 2026, selling an estimated $9.79K and leaving 4,657 shares worth $1.18M. The position accounts for 0.48% of the portfolio, ranked #49.

Seamount Financial Group first reported a position in JNJ in Q4 2023 and has held it in 11 quarters since. 1,808 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Seamount Financial Group held 4,657 shares of Johnson & Johnson worth $1.18M as of Q2 2026.
  • Seamount Financial Group sold 42 Johnson & Johnson shares in Q2 2026, an estimated $9.79K.
  • Johnson & Johnson made up 0.48% of Seamount Financial Group's portfolio in Q2 2026, its #49 holding.
  • Seamount Financial Group first reported a position in Johnson & Johnson in Q4 2023 and has held it in 11 quarters since.
  • 1,808 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Seamount Financial Group's 13F filing for Q2 2026, filed 24 Jul 2026.